• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常男性循环系统中前列环素分泌的估计速率。

Estimated rate of prostacyclin secretion into the circulation of normal man.

作者信息

FitzGerald G A, Brash A R, Falardeau P, Oates J A

出版信息

J Clin Invest. 1981 Nov;68(5):1272-6. doi: 10.1172/jci110373.

DOI:10.1172/jci110373
PMID:7028786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC370922/
Abstract

The rate of secretion of prostacyclin (PGI2) into the circulation of normal man was estimated by measurement of the 2,3-dinor-6-keto-PGF1 alpha (D) and 15-keto-13,14-dihydro-2,3-dinor-6-keto-PGF1 alpha (KDD) urinary metabolites of PGI2. Subjects received 6-h intravenous infusions of vehicle alone and PGI2 at 0.1, 0.4, and 2.0 ng/kg per min in random order. The fractional elimination of the metabolites was independent of the rate of PGI2 infusion. 6.8 +/- 0.3% of the infused PGI2 appeared as D and 4.1 +/- 0.4% as KDD. The regression of infused PGI2 upon the quantities of the two metabolites excreted in excess of control values permitted estimation of the rate of entry of endogenous PGI2 into the circulation corresponding to a given quantity of metabolite excreted. Using the quantities excreted in the 24 h from commencement of the infusions the estimated rates were 0.08 +/- 0.02 ng/kg per min from D and 0.10 +/- 0.03 from KDD. Studies with exogenous PGI2 suggest that infusion rates 2--4 ng/kg per min are required to achieve the threshold for inhibition of platelet function (ex vivo) in man. Although not precluding a role for PGI2 in local platelet-vessel wall interactions, the much lower estimates obtained in this study suggest that endogenous PGI2 is unlikely to act as a circulating antiplatelet agent in healthy man.

摘要

通过测量前列环素(PGI2)的2,3-二去甲-6-酮-PGF1α(D)和15-酮-13,14-二氢-2,3-二去甲-6-酮-PGF1α(KDD)尿代谢产物,估算了正常男性体内前列环素(PGI2)分泌入循环的速率。受试者以随机顺序接受单独静脉输注载体以及分别以0.1、0.4和2.0 ng/kg每分钟的速率静脉输注PGI2,持续6小时。代谢产物的消除分数与PGI2输注速率无关。输注的PGI2中6.8±0.3%以D形式出现,4.1±0.4%以KDD形式出现。根据输注的PGI2与超过对照值排泄的两种代谢产物量之间的回归关系,可以估算出与给定排泄量代谢产物相对应的内源性PGI2进入循环的速率。利用输注开始后24小时内排泄的量,从D估算的速率为0.08±0.02 ng/kg每分钟,从KDD估算的速率为0.10±0.03 ng/kg每分钟。对外源性PGI2的研究表明,在人体中需要2 - 4 ng/kg每分钟的输注速率才能达到抑制血小板功能(体外)的阈值。虽然不排除PGI2在局部血小板 - 血管壁相互作用中的作用,但本研究中获得的低得多的估算值表明,内源性PGI2不太可能在健康男性中作为循环抗血小板剂发挥作用。

相似文献

1
Estimated rate of prostacyclin secretion into the circulation of normal man.正常男性循环系统中前列环素分泌的估计速率。
J Clin Invest. 1981 Nov;68(5):1272-6. doi: 10.1172/jci110373.
2
Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.大鼠中前列环素代谢产物的组织分布及胆汁排泄
J Pharmacol Exp Ther. 1980 Jul;214(1):24-30.
3
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.人前列腺素I2和6-酮-前列腺素F1α的代谢
Artery. 1980;8(1):18-22.
4
Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat.前列环素的代谢。III. 大鼠尿中6-酮基前列腺素F1α的代谢产物谱。
Prostaglandins. 1979 May;17(5):753-9. doi: 10.1016/s0090-6980(79)80047-7.
5
Metabolic disposition of prostacyclin in humans.前列环素在人体内的代谢情况。
J Pharmacol Exp Ther. 1983 Jul;226(1):78-87.
6
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中前列环素降解加速。
Lancet. 1981 Aug 8;2(8241):267-9. doi: 10.1016/s0140-6736(81)90522-5.
7
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.评估外源性前列腺素I2在人体中转化为6-酮-前列腺素E1的程度。
J Pharmacol Exp Ther. 1982 Apr;221(1):183-7.
8
The effect of clinical prostacyclin infusions in advanced arterial disease on platelet function and plasma 6-keto PGF1 alpha levels.
Br J Haematol. 1981 Mar;47(3):413-22. doi: 10.1111/j.1365-2141.1981.tb02809.x.
9
Simultaneous measurement of two major prostacyclin metabolites in urine.尿液中两种主要前列环素代谢物的同步测量。
Clin Chem. 1990 Nov;36(11):1978-80.
10
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.人前列腺素I2和6-酮-前列腺素F1α的代谢
J Biol Chem. 1980 Nov 10;255(21):10194-8.

引用本文的文献

1
Fifty years with aspirin and platelets.阿司匹林与血小板:五十载探索
Br J Pharmacol. 2023 Jan;180(1):25-43. doi: 10.1111/bph.15966. Epub 2022 Nov 3.
2
Prostanoid Metabolites as Biomarkers in Human Disease.前列腺素代谢产物作为人类疾病的生物标志物
Metabolites. 2022 Aug 4;12(8):721. doi: 10.3390/metabo12080721.
3
Measurement of Thromboxane Biosynthesis in Health and Disease.健康与疾病状态下血栓烷生物合成的测定
Front Pharmacol. 2019 Oct 30;10:1244. doi: 10.3389/fphar.2019.01244. eCollection 2019.
4
Cold-Induced Browning of Inguinal White Adipose Tissue Is Independent of Adipose Tissue Cyclooxygenase-2.冷诱导腹股沟白色脂肪组织褐变与脂肪组织环氧化酶-2无关。
Cell Rep. 2018 Jul 24;24(4):809-814. doi: 10.1016/j.celrep.2018.06.082.
5
Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A Proves Renal Origins of Urinary PGI-M and TX-M.患者缺乏细胞质磷脂酶 A 的情况下进行肾移植,证实尿 PGI-M 和 TX-M 的肾来源。
Circ Res. 2018 Feb 16;122(4):555-559. doi: 10.1161/CIRCRESAHA.117.312144. Epub 2018 Jan 3.
6
A new target for squamous cell skin cancer?皮肤鳞状细胞癌的新靶点?
Exp Dermatol. 2015 Jan;24(1):14-5. doi: 10.1111/exd.12576.
7
Major urinary metabolites of 6-keto-prostaglandin F2α in mice.6-酮-前列腺素 F2α 在小鼠体内的主要尿代谢产物。
J Lipid Res. 2013 Jul;54(7):1906-14. doi: 10.1194/jlr.M037192. Epub 2013 May 3.
8
COX-2, the dominant source of prostacyclin.COX-2,前列环素的主要来源。
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):E183. doi: 10.1073/pnas.1219073110. Epub 2013 Jan 4.
9
Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.转化医学的历史教训:环氧化酶抑制和 P2Y12 拮抗作用。
Circ Res. 2013 Jan 4;112(1):174-94. doi: 10.1161/CIRCRESAHA.111.300271.
10
High-fat diet alters prostanoid balance and perfusion in ischemic myocardium of naproxen-treated swine.高脂饮食改变了萘普生治疗猪缺血心肌中的前列腺素平衡和灌注。
Surgery. 2011 Sep;150(3):490-6. doi: 10.1016/j.surg.2011.07.022.

本文引用的文献

1
PGI2-specific antibodies administered in vivo suggest against a role for endogenous PGI2 as a circulating vasodepressor hormone in the normotensive and spontaneously hypertensive rat.体内注射前列环素(PGI2)特异性抗体表明,内源性PGI2在正常血压和自发性高血压大鼠中并非作为循环血管舒张激素发挥作用。
Prostaglandins. 1980 Dec;20(6):1053-60. doi: 10.1016/0090-6980(80)90059-3.
2
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.人前列腺素I2和6-酮-前列腺素F1α的代谢
J Biol Chem. 1980 Nov 10;255(21):10194-8.
3
Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1 alpha in man.人体内前列环素和6-酮前列腺素F1α主要代谢物的鉴定。
Biochim Biophys Acta. 1980 Aug 11;619(2):207-13. doi: 10.1016/0005-2760(80)90069-7.
4
Quantitative determination of 6-Oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry.采用气相色谱-质谱联用法定量测定生物体液中6-氧代前列环素F1α。
Biomed Mass Spectrom. 1980 Nov;7(11-12):544-8. doi: 10.1002/bms.1200071119.
5
Is prostacyclin a physiologically important circulating anti-platelet agent?前列环素是一种具有重要生理意义的循环抗血小板因子吗?
Nature. 1980 Jan 10;283(5743):194-5. doi: 10.1038/283194a0.
6
Prostaglandins: their disappearance from and release into the circulation.前列腺素:它们在循环系统中的消失与释放
Nature. 1967 Dec 2;216(5118):868-73. doi: 10.1038/216868a0.
7
In vivo method for quantitation for anti-platelet potency of drugs.
Naunyn Schmiedebergs Arch Pharmacol. 1978 Mar;302(1):25-30. doi: 10.1007/BF00586592.
8
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.采用气相色谱-质谱联用技术测定人血浆中6-氧代前列环素F1α的含量。
Prostaglandins. 1979 Nov;18(5):731-6. doi: 10.1016/0090-6980(79)90093-5.
9
A double blind placebo controlled crossover study of prostacyclin in man.一项关于前列环素在人体中的双盲安慰剂对照交叉研究。
Life Sci. 1979 Aug 20;25(8):665-72. doi: 10.1016/0024-3205(79)90507-1.
10
Antibodies which antagonise the effects of prostacyclin.拮抗前列环素作用的抗体。
Nature. 1978 Jul 6;274(5666):64-5. doi: 10.1038/274064a0.